SCHEMBL20151848

SCHEMBL20151848

Cc1ccc(C=O)c(N(CCCC(=O)OC(C)OC(=O)C(C)C)Cc2ccccc2)c1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.36
ATM Q13315 3/20 0.36
ALDH1A1 P00352 3/20 0.36
MAPT P10636 2/20 0.36
MAPK1 P28482 2/20 0.36
POLB P06746 2/20 0.35
MEN1 O00255 2/20 0.35
PPARD Q03181 4/20 0.34
ALOX5 P09917 1/20 0.34
PPARA Q07869 3/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
KDM4E B2RXH2 3/20 0.33
NPY1R P25929 1/20 0.32
NPY2R P49146 1/20 0.32
LMNA P02545 1/20 0.32
HSD17B10 Q99714 1/20 0.32
SRC P12931 1/20 0.32
PPARG P37231 2/20 0.32
LTA4H P09960 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20151844 0.91 ALOX5 (0.37) KMT2AATMALDH1A1MAPTMAPK1
SCHEMBL20137125 0.88 MGLL (0.39) ALDH1A1MAPTPOLBPPARDPPARA
SCHEMBL20151843 0.82 PPARD (0.42) KMT2AATMALDH1A1MAPTMAPK1
SCHEMBL20151842 0.82 PPARD (0.36) KMT2AATMALDH1A1MAPTMAPK1
SCHEMBL20151846 0.80 PPARD (0.38) KMT2AATMALDH1A1MAPTMAPK1
SCHEMBL20137060 0.80 MGLL (0.41) ALDH1A1POLBPPARDALOX5PPARA
SCHEMBL20166910 0.76 KDM4E (0.39) ALDH1A1PPARDALOX5PPARAKDM4E
SCHEMBL20151838 0.75 PPARG (0.39) KMT2AALDH1A1MAPTMAPK1MEN1
SCHEMBL20151849 0.75 MGLL (0.56)
SCHEMBL20179985 0.74 PPARG (0.38) ALDH1A1MAPTPOLBPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134674-A1 MAGL INHIBITORS H. LUNDBECK A/S (DK) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134674-A1 MAGL INHIBITORS MAG, MAGI3, MGLL KMT2A 2263/4885ATM 4676/4885ALDH1A1 4349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.